Carla Felice

Padova, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 79 publications

Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.

Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.

Journal: Journal of Crohn's & colitis

Published: September 05, 2026

Clinical Outcomes After Ustekinumab Biosimilar Switching in Crohn's Disease: the USBIOS IG-IBD Study.

Clinical Outcomes After Ustekinumab Biosimilar Switching in Crohn's Disease: the USBIOS IG-IBD Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: June 05, 2026

Corrigendum to 'Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care' [Autoimmunity Reviews 25 (2026) 104068].

Corrigendum to 'Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care' [Autoimmunity Reviews 25 (2026) 104068].

Journal: Autoimmunity reviews

Published: June 04, 2026

Subtotal colectomy with antiperistaltic caecorectal anastomosis versus total colectomy with ileorectal anastomosis for refractory slow-transit constipation: a comparative analysis.

Subtotal colectomy with antiperistaltic caecorectal anastomosis versus total colectomy with ileorectal anastomosis for refractory slow-transit constipation: a comparative analysis.

Journal: Updates in surgery

Published: April 22, 2026

Anti-TNF Drug-Induced Sarcoidosis in Inflammatory Bowel Diseases: Multicentric Case Series and Literature Review.

Anti-TNF Drug-Induced Sarcoidosis in Inflammatory Bowel Diseases: Multicentric Case Series and Literature Review.

Journal: BioMed research international

Published: February 12, 2026

Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.

Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.

Journal: Journal of Crohn's & colitis

Published: November 03, 2025

Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.

Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.

Journal: Journal of Crohn's & colitis

Published: November 03, 2025

Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care.

Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care.

Journal: Autoimmunity reviews

Published: October 25, 2025

Non-infectious pulmonary and gastrointestinal manifestations in primary antibody deficiencies: lessons for the clinic.

Non-infectious pulmonary and gastrointestinal manifestations in primary antibody deficiencies: lessons for the clinic.

Journal: Expert review of clinical immunology

Published: September 16, 2025

Antibodies against integrin αvβ6 have high diagnostic accuracy for ulcerative colitis.

Antibodies against integrin αvβ6 have high diagnostic accuracy for ulcerative colitis.

Journal: Frontiers in immunology

Published: June 04, 2025

Shaping Rare Granulomatous Diseases in the Lab: How New Models Are Changing the Game.

Shaping Rare Granulomatous Diseases in the Lab: How New Models Are Changing the Game.

Journal: Cells

Published: January 13, 2025

Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study.

Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study.

Journal: United European gastroenterology journal

Published: September 24, 2024

Showing 1-12 of 79

Last Updated: 09/26/2026